$73.15
1.11% day before yesterday
Nasdaq, Nov 14, 10:08 pm CET
ISIN
US36266G1076
Symbol
GEHC

GE HealthCare Technologies Stock price

$73.15
+0.81 1.12% 1M
+0.31 0.43% 6M
-5.03 6.43% YTD
-9.77 11.78% 1Y
+13.15 21.92% 3Y
+13.15 21.92% 5Y
+13.15 21.92% 10Y
+13.15 21.92% 20Y
Nasdaq, Closing price Fri, Nov 14 2025
-0.82 1.11%
ISIN
US36266G1076
Symbol
GEHC

New AI Insights on GE HealthCare Technologies Insights AI Insights on GE HealthCare Technologies

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
$33.3b
Enterprise Value
$39.6b
Net debt
$6.3b
Cash
$4.0b
Shares outstanding
455.5m
Valuation (TTM | estimate)
P/E
15.1 | 15.8
P/S
1.6 | 1.6
EV/Sales
2.0 | 1.9
EV/FCF
28.3
P/B
3.3
Dividends
DPS
$0.14
Yield 1Y | 5Y
0.2% | 0.1%
Growth 1Y | 5Y
16.7% | -
Payout 1Y | 3Y
2.8% | 1.8%
Increased
3 Years
Financials (TTM | estimate)
Revenue
$20.2b | $20.9b
EBITDA
$3.3b | $3.7b
EBIT
$2.7b | $3.1b
Net Income
$2.2b | $2.1b
Free Cash Flow
$1.4b
Growth (TTM | estimate)
Revenue
3.5% | 6.4%
EBITDA
6.8% | 15.0%
EBIT
8.9% | 18.1%
Net Income
32.4% | 6.1%
Free Cash Flow
-17.4%
Margin (TTM | estimate)
Gross
40.8%
EBITDA
16.3% | 17.6%
EBIT
13.5%
Net
11.0% | 10.1%
Free Cash Flow
6.9%
Financial Health
Equity Ratio
25.5%
Return on Equity
23.6%
ROCE
10.5%
ROIC
8.7%
Debt/Equity
1.0
More
EPS
$4.8
FCF per Share
$3.1
Short interest
3.3%
Employees
53k
Rev per Employee
$370.0k
Show more

Create a Free Account to create an GE HealthCare Technologies alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

GE HealthCare Technologies Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a GE HealthCare Technologies forecast:

19x Buy
68%
9x Hold
32%

Analyst Opinions

28 Analysts have issued a GE HealthCare Technologies forecast:

Buy
68%
Hold
32%

Financial data from GE HealthCare Technologies

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
20,246 20,246
4% 4%
100%
- Direct Costs 11,986 11,986
4% 4%
59%
8,260 8,260
2% 2%
41%
- Selling and Administrative Expenses 4,244 4,244
1% 1%
21%
- Research and Development Expense 1,282 1,282
0% 0%
6%
3,309 3,309
7% 7%
16%
- Depreciation and Amortization 572 572
2% 2%
3%
EBIT (Operating Income) EBIT 2,737 2,737
9% 9%
14%
Net Profit 2,217 2,217
32% 32%
11%

In millions USD.

Don't miss a Thing! We will send you all news about GE HealthCare Technologies directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

GE HealthCare Technologies Stock News

Neutral
Business Wire
13 days ago
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conference. Jefferies Global Healthcare Conference in London, England – Tuesday, November 18, 2025 at 9:30 am GMT/4:30 am ET/3:30 am CT A webcast of this event can be accessed at the GE HealthCare website: https://investor.gehealthcare.com/news...
Neutral
Seeking Alpha
18 days ago
GE HealthCare Technologies Inc. ( GEHC ) Q3 2025 Earnings Call October 29, 2025 8:30 AM EDT Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President, CEO & Director James Saccaro - VP & CFO Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Travis Steed - BofA Securities, Research Division Joanne Wuensch - Cit...
Positive
Reuters
18 days ago
GE HealthCare Technologies raised its annual adjusted profit forecast and beat estimates for third-quarter results on Wednesday, powered by strong demand for its medical devices in the United States and the Europe, Middle East, and Africa region.
More GE HealthCare Technologies News

Company Profile

GE Healthcare Technologies, Inc. operates as a holding company with interest in providing medical technology, pharmaceutical diagnostics and digital solutions. Its operating segments include Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded on May 16, 2022 and is headquartered in Chicago, IL.

Head office United States
CEO Peter Arduini
Employees 53,000
Founded 2022
Website www.gehealthcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today